OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Precision Oncology in Pancreatic Cancer: Experiences and Challenges of the CCCMunichLMU Molecular Tumor Board
Klara Dorman, Danmei Zhang, Kathrin Heinrich, et al.
Targeted Oncology (2023) Vol. 18, Iss. 2, pp. 257-267
Open Access | Times Cited: 13
Klara Dorman, Danmei Zhang, Kathrin Heinrich, et al.
Targeted Oncology (2023) Vol. 18, Iss. 2, pp. 257-267
Open Access | Times Cited: 13
Showing 13 citing articles:
comprehensive genomic profiling: a public health system perspective
Themistoklis Paraskevas, Michail Papapanou, Theodoros Ν. Sergentanis, et al.
Expert Review of Molecular Diagnostics (2025), pp. 1-9
Closed Access
Themistoklis Paraskevas, Michail Papapanou, Theodoros Ν. Sergentanis, et al.
Expert Review of Molecular Diagnostics (2025), pp. 1-9
Closed Access
A stratified two-stage tumor molecular profiling algorithm to identify clinically actionable molecular alterations in pancreatic cancer
Saskia Hussung, Dilara Akhoundova, Clelia Pistoni, et al.
ESMO Gastrointestinal Oncology (2025) Vol. 7, pp. 100134-100134
Closed Access
Saskia Hussung, Dilara Akhoundova, Clelia Pistoni, et al.
ESMO Gastrointestinal Oncology (2025) Vol. 7, pp. 100134-100134
Closed Access
The roles of lncRNAs and miRNAs in pancreatic cancer: a focus on cancer development and progression and their roles as potential biomarkers
Somayeh Jafari, Hossein Motedayyen, Parisa Javadi, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 3
Somayeh Jafari, Hossein Motedayyen, Parisa Javadi, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 3
Comprehensive Genomic Studies on the Cell Blocks of Pancreatic Cancer
Ricella Souza da Silva, Maria João Pina, Luı́s Cirnes, et al.
Diagnostics (2024) Vol. 14, Iss. 9, pp. 906-906
Open Access | Times Cited: 3
Ricella Souza da Silva, Maria João Pina, Luı́s Cirnes, et al.
Diagnostics (2024) Vol. 14, Iss. 9, pp. 906-906
Open Access | Times Cited: 3
Head‐to‐head comparison of treatment sequences in advanced pancreatic cancer—Real‐world data from the prospective German TPK clinical cohort study
Norbert Marschner, Nils Haug, Susanna Hegewisch‐Becker, et al.
International Journal of Cancer (2024) Vol. 155, Iss. 9, pp. 1629-1640
Open Access | Times Cited: 3
Norbert Marschner, Nils Haug, Susanna Hegewisch‐Becker, et al.
International Journal of Cancer (2024) Vol. 155, Iss. 9, pp. 1629-1640
Open Access | Times Cited: 3
Trametinib in combination with hydroxychloroquine or palbociclib in advanced metastatic pancreatic cancer: data from a retrospective, multicentric cohort (AIO AIO-TF/PAK-0123)
David P. Witte, Ina Pretzell, Timm M. Reißig, et al.
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 10
Open Access | Times Cited: 3
David P. Witte, Ina Pretzell, Timm M. Reißig, et al.
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 10
Open Access | Times Cited: 3
The impact of the multi-disciplinary molecular tumour board and integrative next generation sequencing on clinical outcomes in advanced solid tumours
Aya El Helali, Tai-Chung Lam, Elaine Yee-Ling Ko, et al.
The Lancet Regional Health - Western Pacific (2023) Vol. 36, pp. 100775-100775
Open Access | Times Cited: 6
Aya El Helali, Tai-Chung Lam, Elaine Yee-Ling Ko, et al.
The Lancet Regional Health - Western Pacific (2023) Vol. 36, pp. 100775-100775
Open Access | Times Cited: 6
A Phase III Randomized Trial of Integrated Genomics and Avatar Models for Personalized Treatment of Pancreatic Cancer: the AVATAR Trial
Francesca Sarno, Jair Tenorio, Sofia Perea, et al.
Clinical Cancer Research (2024) Vol. 31, Iss. 2, pp. 278-287
Open Access | Times Cited: 1
Francesca Sarno, Jair Tenorio, Sofia Perea, et al.
Clinical Cancer Research (2024) Vol. 31, Iss. 2, pp. 278-287
Open Access | Times Cited: 1
Implementing precision oncology for sarcoma patients: the CCCLMUmolecular tumor board experience
Luc M. Berclaz, Anton Burkhard‐Meier, Philipp Lange, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 15, pp. 13973-13983
Open Access | Times Cited: 3
Luc M. Berclaz, Anton Burkhard‐Meier, Philipp Lange, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 15, pp. 13973-13983
Open Access | Times Cited: 3
Histopathologische Diagnostik von soliden und zystischen Pankreasläsionen mit Hauptaugenmerk auf dem duktalen Adenokarzinom
Iréne Esposito, Aslihan Yavas, Lena Häberle
Deleted Journal (2024) Vol. 45, Iss. 1, pp. 5-18
Closed Access
Iréne Esposito, Aslihan Yavas, Lena Häberle
Deleted Journal (2024) Vol. 45, Iss. 1, pp. 5-18
Closed Access
Zielgerichtete Therapie des Pankreaskarzinoms
David P. Witte, Klara Dorman, Danmei Zhang, et al.
Gastro-News (2024) Vol. 11, Iss. 3, pp. 34-37
Closed Access
David P. Witte, Klara Dorman, Danmei Zhang, et al.
Gastro-News (2024) Vol. 11, Iss. 3, pp. 34-37
Closed Access
Mutational profiling of 103 unresectable pancreatic ductal adenocarcinomas using EUS-guided fine-needle biopsy
Julie Buchberg, Karin de Stricker, Per Pfeiffer, et al.
Endoscopic Ultrasound (2024) Vol. 13, Iss. 3, pp. 154-164
Open Access
Julie Buchberg, Karin de Stricker, Per Pfeiffer, et al.
Endoscopic Ultrasound (2024) Vol. 13, Iss. 3, pp. 154-164
Open Access
Zielgerichtete Therapie des Pankreaskarzinoms
David P. Witte, Klara Dorman, Danmei Zhang, et al.
Deleted Journal (2023) Vol. 29, Iss. 9, pp. 778-783
Closed Access
David P. Witte, Klara Dorman, Danmei Zhang, et al.
Deleted Journal (2023) Vol. 29, Iss. 9, pp. 778-783
Closed Access
